1. Home
  2. TRML vs MITK Comparison

TRML vs MITK Comparison

Compare TRML & MITK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRML
  • MITK
  • Stock Information
  • Founded
  • TRML 2021
  • MITK 1983
  • Country
  • TRML United States
  • MITK United States
  • Employees
  • TRML N/A
  • MITK N/A
  • Industry
  • TRML Biotechnology: Pharmaceutical Preparations
  • MITK Computer peripheral equipment
  • Sector
  • TRML Health Care
  • MITK Technology
  • Exchange
  • TRML Nasdaq
  • MITK Nasdaq
  • Market Cap
  • TRML 419.1M
  • MITK 408.9M
  • IPO Year
  • TRML N/A
  • MITK N/A
  • Fundamental
  • Price
  • TRML $27.66
  • MITK $9.49
  • Analyst Decision
  • TRML Strong Buy
  • MITK Strong Buy
  • Analyst Count
  • TRML 3
  • MITK 4
  • Target Price
  • TRML $64.67
  • MITK $12.13
  • AVG Volume (30 Days)
  • TRML 202.3K
  • MITK 466.9K
  • Earning Date
  • TRML 11-07-2024
  • MITK 08-08-2024
  • Dividend Yield
  • TRML N/A
  • MITK N/A
  • EPS Growth
  • TRML N/A
  • MITK N/A
  • EPS
  • TRML N/A
  • MITK N/A
  • Revenue
  • TRML N/A
  • MITK $166,517,000.00
  • Revenue This Year
  • TRML N/A
  • MITK $0.58
  • Revenue Next Year
  • TRML N/A
  • MITK $5.51
  • P/E Ratio
  • TRML N/A
  • MITK N/A
  • Revenue Growth
  • TRML N/A
  • MITK N/A
  • 52 Week Low
  • TRML $12.12
  • MITK $7.35
  • 52 Week High
  • TRML $48.31
  • MITK $16.24
  • Technical
  • Relative Strength Index (RSI)
  • TRML 58.78
  • MITK 65.14
  • Support Level
  • TRML $25.10
  • MITK $8.57
  • Resistance Level
  • TRML $28.35
  • MITK $8.80
  • Average True Range (ATR)
  • TRML 1.37
  • MITK 0.23
  • MACD
  • TRML -0.26
  • MITK 0.07
  • Stochastic Oscillator
  • TRML 57.98
  • MITK 92.00

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

About MITK Mitek Systems Inc.

Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It is serving more than 7,800 financial services organizations and leading marketplace and financial technology brands across the globe. Mitek's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.

Share on Social Networks: